Skip to main content
OpenTrials
Completed

NCT Number: NCT06259656

Correlation of Antibody Response to COVID-19 Vaccination in Pregnant Woman and Transplacental Passage Into Cord Blood.

The goal of this study is to study the correlation of maternal and cord blood level of Anti SAR-CoV.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Vachira Phuket Hospital

Phuket, 83000, Thailand

About this study

The goal of this study is to study the correlation of maternal and cord blood level of Anti SAR-CoV. Sample size is 40 Thai patients at labor room Vachira Phuket Hospital in October - November 2023, who have at least one COVID-19 vaccination before or when pregnant. The Secondary outcome is to study time effect after COVID-19 vaccination and effect of vaccine type on Antibody level.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Thai term pregnant women
  • 18-45 year old
  • At least 1 covid vaccination received
  • admission at Vachira Phuket Hospital Labor Room

Exclusion criteria

  • Do not want to participate
  • Unstable or Emergency condition

Treatment and study plan

COVID-19 Spike Protein IgG Quantitative Antibody (CMIA)

Diagnostic Test

Maternal blood and cord blood were collected to test for COVID-19 Spike Protein IgG Quantitative Antibody (CMIA)

Primary outcomes

  1. COVID-19 Spike Protein IgG Quantitative Antibody (CMIA) Level

    Time frame: 1 month

    Test for correlation of level in maternal and cord blood

Secondary outcomes

  1. Analysed time effect from last vaccination and type.

    Time frame: 1 month

    Test for time effect after last dose of vaccination

Sponsors and collaborators

Lead sponsor

Vachira Phuket Hospital

Other

Registry information

Official study title

Antibody Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Pregnant Woman and Transplacental Passage Into Cord Blood.

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Feb 14, 2024
Registry last updated
Jul 3, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.